Principal Investigators Association

NIH SBIR (R43) Application Review Strategies: Ensure a Winning Proposal Before Submitting

The Small Business Innovation Research (SBIR) Program, Phase 1 (R43), is a highly competitive program encouraging small businesses to explore their technological potential by supporting research alone as well as research and product or technology development. You will spend a considerable amount of time and effort putting your application together, and even though you may feel certain that it is error-free and ready to be submitted, the reality is that you are probably mistaken. This happens to all of us. We spend so much time focused on the document that we become blind to a variety of errors including misspellings, grammar, and math. This intense familiarity with the document is precisely the reason why you should give your application one final review before submission.
During this comprehensive Webinar, strategies for breaking down your final grant application review into specific areas, common errors made by applicants, and how much time you should allow to complete this final review, will be presented. Also covered will be allowable post-submission changes. All of this information is geared toward a single goal: to make sure that you have the best chance of being awarded funds by submitting the best possible application.

5 Key Take-Aways:

  • The most common sections of your
    application where errors occur.
  • Errors that the NIH sees most often in
    grant applications.
  • How to tackle the final review in
    manageable pieces.
  • Why having a colleague review the
    application is not enough.
  • Your options if you discover an error
    after submission.

 Who Should Attend:

  • Any scientist currently working at  a small company, as well Principal Investigators, post-docs and graduate students who may be considering a switch from an academic laboratory to a small business research and development laboratory.

Dr. Ludlow began his academic faculty career at the University of Rochester (NY) in 1991, with appointments in the department of biochemistry at the medical school and the university’s cancer research center. During this time he maintained an independently funded research laboratory training graduate students and post doctoral fellows in the area of tumor suppressor gene expression, protein structure, and function. Funding for his laboratory came from a variety of sources, including the NIH, the American Cancer Society, and private foundations. Dr. Ludlow began working in the commercial biotechnology sector in the year 2000, developing and managing research and pre-clinical programs for cell therapy and tissue engineered products, where he has continued to successfully compete in, and advise on, multiple NIH award programs.

Limited-Time Offer:

Purchase this 60-Minute On-Demand Webinar in CD-Rom, MP4 or PDF Transcript for only $99.

*Please note: Each format includes the presentation handouts in PDF. CDs are mailed within 48 hours. A link to the MP4/ PDF Transcript is available immediately after purchase.

Have additional questions?100_Percent

You have the floor with the speaker during an interactive Q&A. Remember, you can submit your questions in advance via email to [email protected].


If you have questions or would like to speak to our Webinar specialist about our site license, please call 800-303-0129 ext 506.

This Webinar presentation is brought to you as a training tool by the Principal Investigators Association, which is an independent organization. The presentation, tools presented and their contents are not connected with the National Institutes of Health (NIH), nor are they endorsed by this agency. All views expressed are those personally held by the presenter and are not official government policies or opinions.


Additional Information

Webinar Format

CD-Rom, MP4, PDF Transcript

SKU: AC150305

Ordering by fax/mail/PO?
Click here.

Your Price:


Choose Your Format:
PDF Transcript